Bioorthogonal chemical engineering of rAAV capsid: Advancing gene therapy targeting using proteins
Authors:
- Maia MarchandMMMaia Marchand
- Sébastien DepienneSDSébastien Depienne
- Mohammed BouzelhaMBMohammed Bouzelha
- Karine PavageauKPKarine Pavageau
- Roxane PeumeryRPRoxane Peumery
- Denis LoquetDLDenis Loquet
- Dimitri Alvarez-DortaDADimitri Alvarez-Dorta
- Mickaël GuilbaudMGMickaël Guilbaud
- Mikaël CroyalMCMikaël Croyal
- Aurélien DupontADAurélien Dupont
- Oumeya AdjaliOAOumeya Adjali
- Sébastien G. GouinSGSébastien G. Gouin
Preprint
- 29 July 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
We report the chemical conjugation of recombinant Adeno Associated Virus (rAAV) capsid with various functionalities, including proteins, using a bioorthogonal strategy. rAAVs were azido-coated or DBCO-coated by chemically modifying lysine or tyrosine residues. Lysine residues were modified using a phenyl isothiocyanate anchor, and tyrosine residues using either an aryldiazonium salt or a N-methyl luminol derivative. We demonstrate anchor- dependent labelling levels, as observed with biochemical assays and mass spectrometry. Strain-promoted azide-alkyne cycloaddition (SPAAC) was then implemented and evaluated on the rAAV to append functionalities such as fluorescein, biotin and carbohydrates to the azido- coated capsids. We confirmed the efficiency of the bioorthogonal reaction and observed a stronger reactivity with dibenzylcyclooctyne (DBCO) compared to bicyclononyne (BCN). The optimized SPAAC reaction was finally used to label the viral vectors with two relevant nanobodies targeting specific immune cell receptors (CD62L and CD45). In vitro transduction assays conducted with one rAAV-nanobody conjugate demonstrated the promising targeting properties of these chemically modified vectors. Thus, we anticipate that this strategy will positively impact the field of rAAV capsid engineering and contribute in tissue-specific targeting for the optimisation of gene therapy treatments.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retinaBiomedicine & Pharmacotherapy, 2024
- Gene‐targeted therapies: Overview and implicationsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2023
- The Therapeutic Potential of NanobodiesBioDrugs, 2019
- Precise Photoremovable Perturbation of a Virus–Host InteractionAngewandte Chemie International Edition, 2017
- A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno‐Associated VirusAngewandte Chemie International Edition, 2016
- Strain-Promoted 1,3-Dipolar Cycloaddition of Cycloalkynes and Organic AzidesTopics in Current Chemistry, 2016
- Bispecific antibodiesDrug Discovery Today, 2015
- Streptavidin–biotin technology: improvements and innovations in chemical and biological applicationsApplied Microbiology and Biotechnology, 2013
- Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45Cellular Signalling, 2010
- A Chemical Labeling Strategy for Proteomics under Nondenaturing ConditionsChemBioChem, 2009